• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Biotech

Annual General Meeting of Active Biotech AB
LUND, SWEDEN--(Marketwired - May 16, 2013) - The Annual General Meeting of Active Biotech was held on May 15, 2013. In accordance with the Board of Directors' proposal, it was resolved that no...(more)
Active Biotech  
May 16, 2013 02:49 ET
 

 

New data to be presented at the 2013 ASCO Annual Meeting show Active Biotech's commitment to oncology research
LUND, SWEDEN--(Marketwired - May 16, 2013) - Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data from two of its oncology projects, the drug candidates tasquinimod for the treatment of...(more)
Active Biotech  
May 16, 2013 02:44 ET
 

 

Algeta ASA: New data and analyses from clinical trials of Xofigo(R) (radium Ra 223 dichloride) to be presented at ASCO
OSLO, NORWAY--(Marketwired - May 16, 2013) - Intended for US Media only Algeta ASA (OSE: ALGETA) announces that further analyses of data subsets from the phase III ALSYMPCA study of the recently...(more)
Algeta ASA  
May 16, 2013 01:42 ET
 

 

Pharming reports on financial results first quarter 2013
LEIDEN, NETHERLANDS--(Marketwired - May 16, 2013) - Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today published its financial report for the...(more)
Pharming Group N.V.  
May 16, 2013 01:06 ET
 

 

Titan Pharmaceuticals Announces First Quarter 2013 Financial Results
SOUTH SAN FRANCISCO, CA--(Marketwired - May 15, 2013) - Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today reported financial results for the first quarter ended March 31, 2013. Net income...(more)
Titan Pharmaceuticals, Inc.  
May 15, 2013 20:30 ET
 

 

Onyx Pharmaceuticals Announces Data Presentations at 49th American Society of Clinical Oncology Annual Meeting
SOUTH SAN FRANCISCO, CA--(Marketwired - May 15, 2013) - Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentations of data highlighting Nexavar® (sorafenib) tablets...(more)
Onyx Pharmaceuticals, Inc.  
May 15, 2013 18:00 ET
 

 

Jennerex Presents Pexa-Vec Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting
CHICAGO, IL--(Marketwired - May 15, 2013) - Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class...(more)
Jennerex  
May 15, 2013 18:00 ET
 

 

Applied DNA Sciences and SmokeCloak, A/S Launch DNA Fog
STONY BROOK, NY--(Marketwired - May 15, 2013) - Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication...(more)
Applied DNA Sciences  
May 15, 2013 17:00 ET
 

 

BioExx Announces Q1 2013 Results
TORONTO, ONTARIO--(Marketwired - May 15, 2013) - BioExx Specialty Proteins Ltd. (TSX:BXI) today announced its financial results for the three months ended March 31, 2013. ...(more)
BioExx Specialty Proteins Ltd.  
May 15, 2013 17:00 ET
 

 

DARA Reports First Quarter 2013 Financial Results and Operational Highlights
RALEIGH, NC--(Marketwired - May 15, 2013) - DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive...(more)
DARA BioSciences, Inc.  
May 15, 2013 16:49 ET